Net debt decreased 68.2%
Net debt changed -68.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$3.2B→$1.0B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MRVL financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Debt / assets moved 369 bp lower
Debt / assets changed -369 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
21.70%→18.01%4 prior comparisons
Cash & equivalents increased 221.2%
Cash & equivalents changed +221.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.2B→$3.9B4 prior comparisons
Total assets increased 33.8%
Total assets changed +33.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$20.6B→$27.6B4 prior comparisons
Operating cash flow increased 31.2%
Operating cash flow changed +31.2% from the comparable as-filed period.
$461.6M→$605.5M3 prior comparisons
Short-term borrowings decreased 100.0%
Short-term borrowings changed -100.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$499.3M→$04 prior comparisons
Revenue increased 36.5%
Revenue changed +36.5% from the comparable as-filed period.
$2.0B→$2.7B2 prior comparisons
Operating income increased 58.5%
Operating income changed +58.5% from the comparable as-filed period.
$290.1M→$459.7M2 prior comparisons
Noncurrent long-term debt increased 25.1%
Noncurrent long-term debt changed +25.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$4.0B→$5.0B4 prior comparisons
Gross margin moved 276 bp higher
Gross margin changed +276 basis points from the comparable as-filed period.
50.38%→53.14%2 prior comparisons
Research & development increased 42.8%
Research & development changed +42.8% from the comparable as-filed period.
$519.0M→$741.1M2 prior comparisons
Operating margin moved 232 bp higher
Operating margin changed +232 basis points from the comparable as-filed period.
14.46%→16.78%2 prior comparisons
Working capital / assets moved 940 bp higher
Working capital / assets changed +940 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
10.27%→19.67%4 prior comparisons
Cash / debt moved 5184 bp higher
Cash / debt changed +5184 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
27.41%→79.24%4 prior comparisons
Current ratio increased 68.4%
Current ratio changed +68.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
1.88→3.174 prior comparisons
Current assets increased 75.5%
Current assets changed +75.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$4.5B→$7.9B4 prior comparisons
Working capital increased 156.4%
Working capital changed +156.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.1B→$5.4B4 prior comparisons
Trade receivables increased 52.8%
Trade receivables changed +52.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.5B→$2.2B4 prior comparisons
Gross profit increased 44.0%
Gross profit changed +44.0% from the comparable as-filed period.
$1.0B→$1.5B2 prior comparisons
SBC / revenue moved 425 bp higher
SBC / revenue changed +425 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
7.66%→11.91%2 prior comparisons
Inventory increased 29.4%
Inventory changed +29.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.1B→$1.4B4 prior comparisons
Cost of revenue increased 29.0%
Cost of revenue changed +29.0% from the comparable as-filed period.
$995.5M→$1.3B2 prior comparisons
Selling, general & administrative increased 33.6%
Selling, general & administrative changed +33.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$192.8M→$257.6M2 prior comparisons
Capex / revenue moved 226 bp higher
Capex / revenue changed +226 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.37%→4.63%2 prior comparisons
Shares outstanding increased 1.7%
Shares outstanding changed +1.7% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
862,100,000→876,900,0008 prior comparisons
Reported total debt increased 11.1%
Reported total debt changed +11.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$4.5B→$5.0B4 prior comparisons
Gross debt increased 11.1%
Gross debt changed +11.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$4.5B→$5.0B4 prior comparisons
Capital expenditure increased 166.7%
Capital expenditure changed +166.7% from the comparable as-filed period.
$47.5M→$126.7M3 prior comparisons
Stock-based compensation increased 112.4%
Stock-based compensation changed +112.4% from the comparable as-filed period.
$153.6M→$326.2M3 prior comparisons
Inventory / revenue moved 275 bp lower
Inventory / revenue changed -275 basis points from the comparable as-filed period.
52.42%→49.67%2 prior comparisons
Free-cash-flow proxy increased 15.6%
Free-cash-flow proxy changed +15.6% from the comparable as-filed period.
$414.1M→$478.8M3 prior comparisons
Debt / revenue moved 4151 bp lower
Debt / revenue changed -4151 basis points from the comparable as-filed period.
222.68%→181.17%2 prior comparisons
Free-cash-flow margin moved 316 bp lower
Free-cash-flow margin changed -316 basis points from the comparable as-filed period.
20.64%→17.48%2 prior comparisons
Receivables / revenue moved 862 bp higher
Receivables / revenue changed +862 basis points from the comparable as-filed period.
72.36%→80.98%2 prior comparisons
R&D / revenue moved 118 bp higher
R&D / revenue changed +118 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
25.87%→27.05%2 prior comparisons
Operating cash-flow margin moved 91 bp lower
Operating cash-flow margin changed -91 basis points from the comparable as-filed period.
23.01%→22.10%2 prior comparisons
Current liabilities increased 4.2%
Current liabilities changed +4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.4B→$2.5B4 prior comparisons
Revenue increased 27.6%
Revenue changed +27.6% from the comparable as-filed period.
$1.9B→$2.4B0 prior comparisons
Research & development increased 28.5%
Research & development changed +28.5% from the comparable as-filed period.
$507.7M→$652.3M0 prior comparisons
Operating income increased 25.4%
Operating income changed +25.4% from the comparable as-filed period.
$270.6M→$339.4M0 prior comparisons
Operating cash flow increased 91.9%
Operating cash flow changed +91.9% from the comparable as-filed period.
$332.9M→$638.8M0 prior comparisons
Net income decreased 80.6%
Net income changed -80.6% from the comparable as-filed period.
$177.9M→$34.5M0 prior comparisons
Operating margin decreased by 0.24 points
Operating margin moved -0.24 percentage points from the comparable as-filed period.
14.28%→14.04%0 prior comparisons
Gross profit increased 32.4%
Gross profit changed +32.4% from the comparable as-filed period.
$952.4M→$1.3B0 prior comparisons
Free-cash-flow proxy increased 125.6%
Free-cash-flow proxy changed +125.6% from the comparable as-filed period.
$214.1M→$483.1M0 prior comparisons
Cash & equivalents increased 333.9%
Cash & equivalents changed +333.9% from the comparable as-filed period.
$885.9M→$3.8B0 prior comparisons
Capital expenditure increased 31.1%
Capital expenditure changed +31.1% from the comparable as-filed period.
$118.8M→$155.7M0 prior comparisons
Inventory increased 30.8%
Inventory changed +30.8% from the comparable as-filed period.
$1.1B→$1.4B0 prior comparisons
Capex / revenue increased by 0.17 points
Capex / revenue moved +0.17 percentage points from the comparable as-filed period.
6.27%→6.44%0 prior comparisons
Gross margin increased by 1.90 points
Gross margin moved +1.90 percentage points from the comparable as-filed period.
50.25%→52.15%0 prior comparisons
Debt increased 17.2%
Debt changed +17.2% from the comparable as-filed period.
$4.2B→$5.0B0 prior comparisons
Stock-based compensation increased 46.1%
Stock-based compensation changed +46.1% from the comparable as-filed period.
$142.1M→$207.6M0 prior comparisons
Selling, general & administrative increased 38.6%
Selling, general & administrative changed +38.6% from the comparable as-filed period.
$186.4M→$258.4M0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.